Multi-kinase-IN-2 is an orally active angiokinase inhibitor with potent inhibitory activity against angiokinases including VEGFR-1/2/3, PDGFRα/β, FGFR-1, as well as LYN and c-KIT kinases; it significantly suppresses phosphorylation of AKT and ERK proteins, induces apoptosis, and exhibits anticancer activity.